MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/13543784.2024.2312216

Медицинская библиотека · Expert opinion on investigational drugs · 2024

New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology.

Zhou Xingyu, Xu Dong, Li Mengtao, Zeng Xiaofeng

СтатьяОбзорПеревод пока не подготовлен

Аннотация

INTRODUCTION

Sjögren's syndrome is a heterogeneous autoimmune condition that impairs quality of life because of dryness, fatigue, pain, and systemic involvements. Current treatment largely depends on empirical evidence, with no effective therapy approved. Clinical trials on targeted drugs often fail to report efficacy due to common factors.

AREAS COVERED: This review summarizes the pathogenesis and what caused the failure of new investigational drugs in clinical trials, highlighting solutions for more effective investigations, with greater consistency between research outcomes, clinical use, and patient needs.

EXPERT OPINION: Unlinked pathobiology with symptoms resulted in misidentified targets and disappointing trials. Useful stratification tools are necessary for the heterogeneous SS patients. Composite endpoints or improvements in ESSDAI scores are needed, considering the high placebo response, and the unbalance between symptom burden and disease activity. Compared to classic biologics, targeted cell therapy will be a more promising field of investigation in the coming years.

Для цитирования: Zhou Xingyu, Xu Dong, Li Mengtao, Zeng Xiaofeng. New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology.. Expert opinion on investigational drugs. 2024. DOI: 10.1080/13543784.2024.2312216.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.